Due to the multifocal nature of prostate cancer, we detected CRMP4 methylation in different parts of tumor tissues, and the results showed that there was no difference in the value of CRMP4 methylation in different parts of tumor in the same patient. The gene discussed is DPYSL3; the disease is neoplasm.